DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Moritoki Y, Tsuneyama K, Nakamura Y. , et al.
Anti-drug antibodies against a novel humanized anti-CD20 antibody impair its therapeutic effect on primary biliary cholangitis in human CD20- and FcγR-expressing mice.
Front Immunol 2018;
9: 2534
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.